Search

Search Constraints

You searched for: Author/Creator Sydes, Matthew R.

Search Results

1. Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476). Issue 3 (16th May 2022)

2. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. (October 2017)

3. Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative. Issue 3 (February 2015)

6. Erratum to 'Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma' [Eur J Cancer 170 (2022) 209-235]. (December 2022)

7. Help for Future Research: Lessons Learned in Trial Design, Recruitment, and Delivery From the "hELP" Study. Issue 4 (October 2018)

8. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Issue 3 (December 2016)

9. Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings. (January 2022)

10. Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma. (July 2022)